Abstract:Petro Virych, 1 Pavlo Virych, 2 Volodymyr Prokopiuk, 3, 4 Anatolii Onishchenko, 3 Mykola Ischenko, 2 Volodymyr Doroschuk, 2 Valentyna Kurovska, 5 Anton Tkachenko, 4 Nataliya Kutsevol 2 1 Laboratory of Mechanisms of Drug Resistance, R.E. Kavetsky Institute for Experimental Pathology, Oncology and Radiobiology, Kyiv, Ukraine; 2 Faculty of Chemistry, Taras Shevchenko National University of Kyiv, Kyiv, Ukraine; 3 Research Institute of Experimental and Clinical Medicine, Kharkiv National Medical University, Kharkiv, Ukraine; 4 Department of Cryobiochemistry, Institute for Problems of Cryobiology and Cryomedicine of the National Academy of Sciences of Ukraine, Kharkiv, Ukraine; 5 Educational and Scientific Center "Institute of Biology and Medicine", Taras Shevchenko National University of Kyiv, Kyiv, Ukraine Correspondence: Pavlo Virych, Faculty of Chemistry, Taras Shevchenko National University of Kyiv, 60 Volodymyrska str, Kyiv, 01601, Ukraine, Email Anton Tkachenko, Department of Cryobiochemistry, Institute for Problems of Cryobiology and Cryomedicine of the National Academy of Sciences of Ukraine, 23 Pereyaslavskaya St, Kharkiv, 61015, Ukraine, Email Introduction: Tumor drug resistance and systemic toxicity are major challenges of modern anticancer therapy. Nanotechnology makes it possible to create new materials with the required properties for anticancer therapy. Methods: In this research, Dextran-graft-Polyacrylamide/ZnO nanoparticles were used. The study was carried out using prostate (DU-145, LNCaP, PC-3), breast (MDA-MB-231, MCF-7, MCF-7 Dox) cancer cells and non-malignant (MAEC, BALB/3T3 clone A31) cells. Zinc was visualized with fluorescence in vitro and in vivo. ROS and apoptotic markers were identified by cytometry. Zinc accumulation and histopathological changes in the tumor, liver, kidney, and spleen were evaluated in a rat model. Results: ZnO nanoparticles dissociation and release of Zn 2+ into the cytosol occurs in 2– 3 hours for cancerous and non-cancerous cells. ROS upregulation was detected in all cells. For non-malignant cells, the difference between the initial ROS level was insignificant. The rate of carbohydrate metabolism in cancer cells was reduced by nanosystems. Zinc level in the tumor was upregulated by 25% and 39% after treatment with nanosystems and doxorubicin combined, respectively. The tumor Walker-256 carcinosarcoma volume was reduced twice following mono-treatment with the nanocomplex and 65-fold lower when the nanocomplex was combined with doxorubicin compared with controls. In the liver, kidney and spleen, the zinc level increased by 10– 15% but no significant pathological alterations in the tissues were detected. Conclusion: D-PAA/ZnO NPs nanosystems were internalized by prostate, breast cancer cells and non-malignant cells via endocytosis after short time, but cytotoxicity against non-cancer cells were significantly lower in vitro and in vivo. D-PAA/ZnO NPs nanocomplex efficiently promoted cell death of tumor cells without showing cytotoxicity against non-malignant cells making it a promising anti-cancer agent. Keywords: zinc oxide nanoparticles, doxorubicin, prostate cancer, breast cancer, zinc imaging, histopathology The last few decades have witnessed significant advances in nanotechnology. The organization of materials into nanoscale structures noticeably changes their properties. Nanosize-mediated characteristics allow nanoparticles to interact with cellular structures in a special way. 1 All nanomaterials have a large surface area-to- volume ratio, which significantly increases their reaction properties. Despite significant progress in nanomedicine, our knowledge of intricate mechanisms that govern interactions between nanomaterials, cells and tissues are still ambiguous. 2 Zinc oxide nanoparticles (ZnO NPs) have semiconductor properties, which allow them to be applied in electronics, optics, photocatalysis, cosmetics, and medicine. 3 There is abundant evidence that zinc is low-toxic to cells at physiological conditions (pH = 7.4). 4 ZnO NPs have a high biocompatibility due to weak dissociation and Zn 2+ release. Nevertheless, it has been reported that ZnO NPs cause oxidative stress and cell damage at slightly acidic pH. Tumor cells stimulate significant changes in environmental tissues. Tumor microenvironment (TME) of various cancer types is different, but hallmark features include blood vessels, immune cells and extracellular matrix. The TME dynamically changes in response to hypoxia and decreased pH. The Warburg effect promotes the production of lactate and its efflux in -Abstract Truncated-

Protein functionalization of ZnO nanostructure exhibits selective and enhanced toxicity to breast cancer cells through oxidative stress-based cell death mechanism

Tailoring ZnO nanoparticles for biomedical applications: Surface functionalization of ZnO nanoparticles with 2-oxo-2H-chromene-3-carboxylic acid coupled beta-cyclodextrin for enhanced antimicrobial and anticancer effect

Doxorubicin-Conjugated Zinc Oxide Nanoparticles, Biogenically Synthesised Using a Fungus Aspergillus niger, Exhibit High Therapeutic Efficacy against Lung Cancer Cells

Phytofabrication of biocompatible zinc oxide nanoparticle using Gymnema sylvestre and its potent in vitro antibacterial, antibiofilm, and cytotoxicity against human breast cancer cells (MDA-MB-231)

Electrospun zinc oxide nanoscaffolds: a targeted and selective anticancer approach

A Role of Zno Nanoparticle Electrostatic Properties in Cancer Cell Cytotoxicity

Biosynthesis of Zinc Oxide Nanoparticles Using Bacillus paramycoides for In Vitro Biological Activities and In Vivo Assessment Against Hepatorenal Injury Induced by CCl4 in Rats

SnO2-Doped ZnO/Reduced Graphene Oxide Nanocomposites: Synthesis, Characterization, and Improved Anticancer Activity via Oxidative Stress Pathway

Anticancer and genotoxicity effect of (Clausena lansium (Lour.) Skeels) Peel ZnONPs on neuroblastoma (SH-SY5Y) cells through the modulation of autophagy mechanism

Dextran-Graft-Polyacrylamide/Zinc Oxide Nanoparticles Inhibit of Cancer Cells in vitro and in vivo

Targeted biocompatible Zn-metal-organic framework nanocomposites for intelligent chemotherapy of breast cancer cells

Inhibitory Effect of Zinc Oxide Nanorod Arrays on Breast Cancer Cells Profiled Through Real‐time Cytokines Screening by a Single‐cell Microfluidic Platform (3/2023)

Synthesis, Characterization, and Evaluation of the Antimicrobial and Anticancer Activities of Zinc Oxide and Aluminum-Doped Zinc Oxide Nanocomposites

Lanthanide-Doped ZnO Nanoparticles: Unraveling Their Role in Cytotoxicity, Antioxidant Capacity, and Nanotoxicology

Polyethylene glycol functionalized zinc oxide nanoparticle with excellent photocatalytic performance and oxidative stress mediated bacterial cell death

ZnO nanomaterials target mitochondrial apoptosis and mitochondrial autophagy pathways in cancer cells

Zinc Oxide nanoparticles induce oxidative and proteotoxic stress in ovarian cancer cells and trigger apoptosis Independent of p53-mutation status

Aluminum doping tunes band gap energy level as well as oxidative stress-mediated cytotoxicity of ZnO nanoparticles in MCF-7 cells

Cytotoxic Potencies of Zinc Oxide Nanoforms in A549 and J774 Cells

Morinda citrifolia leaf assisted synthesis of ZnO decorated Ag bio-nanocomposites for in-vitro cytotoxicity, antimicrobial and anticancer applications

Synthesis and characterization of mesoporous zinc oxide nanoparticles and evaluation of their biocompatibility in L929 fibroblasts